Literature DB >> 20554330

Memory CD4+CD127high T cells from patients with multiple sclerosis produce IL-17 in response to myelin antigens.

Koen Venken1, Niels Hellings, Karen Hensen, Jean-Luc Rummens, Piet Stinissen.   

Abstract

Myelin-reactive T helper-17 cells are implicated in the pathogenesis of multiple sclerosis (MS). Here, we analyzed the reactivity of peripheral naive and memory conventional CD4(+)CD127(high) T cells (Tconv) of MS patients and healthy controls (HC) towards myelin basic protein (MBP), myelin oligodendrocyte glycoprotein (MOG) and tetanus toxoid (TT). Proliferative responses of Tconv cells towards MBP, MOG and TT were not significantly different between MS patients and HC. However, MBP and MOG but not TT reactive memory Tconv cells from MS patients, in contrast to HC, produced IL-17. These results suggest that myelin antigen reactive Th-17 cells are enriched in MS patients.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20554330     DOI: 10.1016/j.jneuroim.2010.05.025

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  14 in total

1.  Dysregulation of the IL-23/IL-17 axis and myeloid factors in secondary progressive MS.

Authors:  Amanda K Huber; Lu Wang; Peisong Han; Xu Zhang; Sven Ekholm; Ashok Srinivasan; David N Irani; Benjamin M Segal
Journal:  Neurology       Date:  2014-09-24       Impact factor: 9.910

2.  NDR1 protein kinase promotes IL-17- and TNF-α-mediated inflammation by competitively binding TRAF3.

Authors:  Chunmei Ma; Wenlong Lin; Zhiyong Liu; Wei Tang; Rahul Gautam; Hui Li; Youcun Qian; He Huang; Xiaojian Wang
Journal:  EMBO Rep       Date:  2017-02-20       Impact factor: 8.807

Review 3.  IL-17 producing T cells in mouse models of multiple sclerosis and rheumatoid arthritis.

Authors:  Bernadette Pöllinger
Journal:  J Mol Med (Berl)       Date:  2012-01-10       Impact factor: 4.599

Review 4.  Immune reconstitution therapy (IRT) in multiple sclerosis: the rationale.

Authors:  Dimitrios Karussis; Panayiota Petrou
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

5.  T-cell responses after haematopoietic stem cell transplantation for aggressive relapsing-remitting multiple sclerosis.

Authors:  Joachim Burman; Moa Fransson; Thomas H Tötterman; Jan Fagius; Sara M Mangsbo; Angelica S I Loskog
Journal:  Immunology       Date:  2013-10       Impact factor: 7.397

6.  Th17 response and inflammatory autoimmune diseases.

Authors:  Janelle C Waite; Dimitris Skokos
Journal:  Int J Inflam       Date:  2011-11-15

Review 7.  Antigen Presentation, Autoantigens, and Immune Regulation in Multiple Sclerosis and Other Autoimmune Diseases.

Authors:  Christine Riedhammer; Robert Weissert
Journal:  Front Immunol       Date:  2015-06-17       Impact factor: 7.561

Review 8.  Autoimmune T-cell reactivity to myelin proteolipids and glycolipids in multiple sclerosis.

Authors:  Judith M Greer
Journal:  Mult Scler Int       Date:  2013-11-07

9.  Non-thermal atmospheric plasma ameliorates imiquimod-induced psoriasis-like skin inflammation in mice through inhibition of immune responses and up-regulation of PD-L1 expression.

Authors:  Yun Sang Lee; Myung-Hoon Lee; Hang-Jun Kim; Ho-Ryun Won; Chul-Ho Kim
Journal:  Sci Rep       Date:  2017-11-14       Impact factor: 4.379

10.  A cannabigerol derivative suppresses immune responses and protects mice from experimental autoimmune encephalomyelitis.

Authors:  Francisco J Carrillo-Salinas; Carmen Navarrete; Miriam Mecha; Ana Feliú; Juan A Collado; Irene Cantarero; María L Bellido; Eduardo Muñoz; Carmen Guaza
Journal:  PLoS One       Date:  2014-04-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.